Drug discovery biotech firm Chemotargets and the Centre for Genomic Regulation (CRG) have signed a strategic agreement to accelerate the development of new targeted therapies that respond to unmet ...
Read morePediatric oncologists are forced to adjust adult cancer treatments for childhood cancer due to insufficient specific therapies for children with cancer.
Read moreDr Franco has presented in the online seminars of the College of Biologists of Catalonia new very effective treatments against hepatitis C, designed against three proteins essential for the replicatio...
Read moreGoal is to explore effects of LSD1 inhibition on animal models of autism in Shank3 deficient mice models
Read moreWhile the coronavirus outbreak grows worldwide, at SOM Biotech we continue working on our pipeline to bring therapies for patients with rare diseases.
Read moreThe Department of Health, through the General Direction fo Research and Innovation in Health (DGRI) and in collaboration with Biocat, will finance with 4 million euros a total of 19 research and innov...
Read moreThe mechanism does not activate the reduction of oxygen in the cells of the tumor, contrary to what common drugs, called anti-angiogenic, usually cause
Read moreThe discovery is based on targeting the tissue surrounding the tumor, instead of the tumor directly
Read moreOryzon Genomics has announced today the inclusion of the first two p atient s in a Phase IIa clinical study with Iadademstat (ORY - 1001) in Small Cell Lung Cancer (SCLC) patients .
Read more